FAPI-34

• Description :

  FAPI-34 is a fibroblast-activating protein (FAP) inhibitor with favorable pharmacokinetic and biochemical properties. (patent WO2019154886A1) .

• UNSPSC :

  12352005

• Target :

  FAP

• Type :

  Reference compound

• Related Pathways :

  Immunology/Inflammation

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/fapi-34.html

• Purity :

  99.67

• Solubility :

  DMSO : 160 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles :

  O=C(C1=CC=NC(C=C2)=C1C=C2OCCCN(CC3)CCN3C(CN(CC4=NC=CN4CC(N[C@H](C(O)=O)CC(C(O)=O)C(O)=O)=O)CC5=NC=CN5CC(N[C@H](C(O)=O)CC(C(O)=O)C(O)=O)=O)=O)NCC(N(CC6(F)F)[C@@H](C6)C#N)=O

• Molecular Formula :

  C50H57F2N13O18

• Molecular Weight :

  1166.06

• References & Citations :

  [1]Uwe Haberkorn, et al. Fap inhibitor. WO2019154886A1.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2374782-07-5]